triiodothyronine has been researched along with Multiple Myeloma in 6 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the prevalence of euthyroid hypertriiodothyroninemia and/or hyperthyroxinemia and its clinical characteristics in multiple myeloma (MM) patients." | 8.02 | The Prevalence of Euthyroid Hypertriiodothyroninemia in Newly Diagnosed Multiple Myeloma and its Clinical Characteristics. ( Chen, Z; Hu, Y; Liu, A; Pan, Q; Wang, G; Zhang, W; Zhang, Y, 2021) |
| "To evaluate the prevalence of euthyroid hypertriiodothyroninemia and/or hyperthyroxinemia and its clinical characteristics in multiple myeloma (MM) patients." | 4.02 | The Prevalence of Euthyroid Hypertriiodothyroninemia in Newly Diagnosed Multiple Myeloma and its Clinical Characteristics. ( Chen, Z; Hu, Y; Liu, A; Pan, Q; Wang, G; Zhang, W; Zhang, Y, 2021) |
| "This integrin is overexpressed in multiple myeloma (MM) and other cancers." | 1.40 | Thyroid hormone regulates adhesion, migration and matrix metalloproteinase 9 activity via αvβ3 integrin in myeloma cells. ( Ashur-Fabian, O; Baharal, T; Cohen, K; Davis, PJ; Ellis, M; Erez, D; Flint, N; Hercbergs, A; Shalev, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, Q | 1 |
| Zhang, Y | 1 |
| Zhang, W | 1 |
| Hu, Y | 1 |
| Chen, Z | 1 |
| Liu, A | 1 |
| Wang, G | 1 |
| Cohen, K | 3 |
| Ellis, M | 3 |
| Shinderman, E | 1 |
| Khoury, S | 2 |
| Davis, PJ | 3 |
| Hercbergs, A | 3 |
| Ashur-Fabian, O | 3 |
| Flint, N | 1 |
| Shalev, S | 1 |
| Erez, D | 1 |
| Baharal, T | 1 |
| Cissewski, K | 1 |
| Faix, JD | 1 |
| Reinwein, D | 1 |
| Moses, AC | 1 |
| van Zaanen, HC | 1 |
| Romijn, JA | 1 |
| Sauerwein, HP | 1 |
| Lokhorst, HM | 1 |
| Warnaar, SO | 1 |
| Aarden, LA | 1 |
| Endert, E | 1 |
| van Oers, MH | 1 |
6 other studies available for triiodothyronine and Multiple Myeloma
| Article | Year |
|---|---|
The Prevalence of Euthyroid Hypertriiodothyroninemia in Newly Diagnosed Multiple Myeloma and its Clinical Characteristics.
Topics: Humans; Multiple Myeloma; Prevalence; Thyrotropin; Thyroxine; Triiodothyronine | 2021 |
Relevance of the thyroid hormones-αvβ3 pathway in primary myeloma bone marrow cells and to bortezomib action.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Bone Marrow Cell | 2015 |
Thyroid hormone regulates adhesion, migration and matrix metalloproteinase 9 activity via αvβ3 integrin in myeloma cells.
Topics: Bortezomib; Cell Adhesion; Cell Movement; Cell Proliferation; Humans; Matrix Metalloproteinase 9; Mu | 2014 |
Thyroid hormone is a MAPK-dependent growth factor for human myeloma cells acting via αvβ3 integrin.
Topics: Cell Growth Processes; Cell Line, Tumor; Humans; Integrin alphaVbeta3; Mitogen-Activated Protein Kin | 2011 |
Factitious hyperthyroxinemia due to a monoclonal IgA in a case of multiple myeloma.
Topics: Antibodies, Monoclonal; False Positive Reactions; Female; Humans; Immunoelectrophoresis; Immunoglobu | 1993 |
Modulation of chronic excessive interleukin-6 production in multiple myeloma does not affect thyroid hormone concentrations.
Topics: Aged; Animals; Antibodies, Monoclonal; Biological Assay; Female; Humans; Immunoglobulin G; Infusions | 1997 |